Even if not statistically significant, a sub stratification according to different therapies in this category showed a trend of better PFS outcome for +1q patients treated with lenalidomide.
← all excerpts
P22 THE PROGNOSTIC ROLE OF 1Q ABNORMALITIES IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
1
—
—